Eyeworld Daily News

2016 ASCRS New Orleans Daily Sunday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/677085

Contents of this Issue

Navigation

Page 2 of 104

©2016 Shire US Inc., Lexington, MA 02421 S11927 03/16 Looking deeper Exploring innovation Shire's Vision for Ophthalmics At Shire, we're a leading biotech with a global track record for our work in rare diseases and specialty conditions. Now we're expanding our vision and bringing the same commitment to ophthalmics. Pursuing the promise of new therapies in ophthalmics to address patients' unmet needs. Just watch. Visit Shire-Eyes.com Visit us at Booth 2245 ©2016 Shire US Inc., Lexington, MA 02421 S11927 03/16 Looking deeper Exploring innovation Shire's Vision for Ophthalmics At Shire, we're a leading biotech with a global track record for our work in rare diseases and specialty conditions. Now we're expanding our vision and bringing the same commitment to ophthalmics. Pursuing the promise of new therapies in ophthalmics to address patients' unmet needs. Just watch. Visit Shire-Eyes.com Visit us at Booth 2245 ©2016 Shire US Inc., Lexington, MA 02421 S11927 03/16 Looking deeper Exploring innovation Shire's Vision for Ophthalmics At Shire, we're a leading biotech with a global track record for our work in rare diseases and specialty conditions. Now we're expanding our vision and bringing the same commitment to ophthalmics. Pursuing the promise of new therapies in ophthalmics to address patients' unmet needs. Just watch. Visit Shire-Eyes.com Visit us at Booth 2245 ©2016 Shire US Inc., Lexington, MA 02421 S11927 03/16 Looking deeper Exploring innovation Shire's Vision for Ophthalmics At Shire, we're a leading biotech with a global track record for our work in rare diseases and specialty conditions. Now we're expanding our vision and bringing the same commitment to ophthalmics. Pursuing the promise of new therapies in ophthalmics to address patients' unmet needs. Just watch. Visit Shire-Eyes.com Visit us at Booth 2245 ©2016 Shire US Inc., Lexington, MA 02421 S11927 03/16 Looking deeper Exploring innovation Shire's Vision for Ophthalmics At Shire, we're a leading biotech with a global track record for our work in rare diseases and specialty conditions. Now we're expanding our vision and bringing the same commitment to ophthalmics. Pursuing the promise of new therapies in ophthalmics to address patients' unmet needs. Just watch. Visit Shire-Eyes.com Visit us at Booth 2245

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2016 ASCRS New Orleans Daily Sunday